`Me too' drugs assets, not liabilities to healthcare

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.445, 2004-01, pp. : 5-5

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

`Me too' drugs assets, not liabilities to healthcare

Inpharma, Vol. 1, Iss. 1421, 2004-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Should Financial Incentives be Used to Differentially Reward `Me-Too' and Innovative Drugs?

By Pekarsky Brita

PharmacoEconomics, Vol. 28, Iss. 1, 2010-01 ,pp. : 1-17

Adis International

Access to resources Recommend Favorite

Drugs: no such thing as too much information

Inpharma, Vol. 1, Iss. 1513, 2005-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Central G-Protein Coupled Receptors (GPCR)s as Molecular Targets for the Treatment of Obesity: Assets, Liabilities and Development Status

Current Drug Targets-CNS & Neurological Disorders, Vol. 3, Iss. 5, 2004-01 ,pp. : 357-377

Bentham Science Publishers

Access to resources Recommend Favorite

TV adverts for drugs too simplistic in the US

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 522, 2007-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite